ProMIS Neurosciences Inc. (PMN): Nasdaq/NYSE listing notice — ProMIS Neurosciences receives Nasdaq minimum bid price deficiency notice; has until July 2, 2025 to regain compliance

ProMIS Neurosciences Inc.

Received Nasdaq notice on Jan 3, 2025 for failing $1 minimum bid price rule for 30 consecutive trading days.
Has 180 calendar days (until July 2, 2025) to regain compliance by closing bid price >= $1 for 10 consecutive days.
If not compliant, may be eligible for an additional 180-day period if meets other listing standards and provides intention to cure.
Company will consider options to regain compliance but no assurance of success; shares continue trading under PMN.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ProMIS Neurosciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 3, 2025, ProMIS Neurosciences Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s common shares

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ProMIS Neurosciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 3, 2025, ProMIS Neurosciences Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s common shares, no par value (the “Common Shares”) failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) based upon the closing bid price of the Common Shares for the 30 consecutive trading days prior to the date of the Minimum Bid Price Notice from Nasdaq. The Notice has n

View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.